SV

Sejal Viral Dave

Active Director Director DIN 10471284
DIN 10471284 First appointment Jan 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Sejal Viral Dave

Data last updated:

Sejal Viral Dave is a Director at Stl Pharma Private Limited (since 2024). The company operates in Healthcare. Stl Pharma Private Limited reported revenue of ₹73.55 Cr (FY 2024).

DIN 10471284
Primary Designation Director
Industry Healthcare
First Appointment 24 Jan 2024
Oldest Company Age 16 yrs
Largest company Stl Pharma Private Limited · ₹73.55 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stl Pharma Private Limited U24100MH2010PTC201926
Director24 Jan 20242010₹73.55 Cr (FY 2024)Active

Board colleagues of Sejal Viral Dave

Directorship timeline

Open interactive timeline →
Stl Pharma Private Limited
Premium access

Shareholding and investment profile for Sejal Viral Dave

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sejal Viral Dave

Sejal Viral Dave currently holds 1 directorship: Stl Pharma Private Limited (Director, since 24 Jan 2024, revenue ₹73.55 Cr (FY 2024)).

Sejal Viral Dave was first appointed on 24 Jan 2024 as Director at Stl Pharma Private Limited.

The current boards of Sejal Viral Dave's companies include Jitendra Venilal Dave (Stl Pharma Private Limited), Viral Jitendra Dave (Stl Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available